MedBioInformatics Solutions

Unlocking the potential of genomics for healthcare and drug R&D.
We provide the DISGENET plus knowledge platform.

[MedBioInformatics Solutions @MedBioSolutions]

🗣️New release of DISGENET plus (v23)
🐁New data source: Mouse Genome Database
🧬10% increase in the number of GDAs: more than 175K new GDAs available
⚕️2.5K new diseases and phenotypes incorporated into the database
👉🏽More info at https://t.co/BkFWLByXuN

[DisGeNET @DisGeNET]

UniProt, the reference resource for proteins, provides links to DISGENET plus.
Links to DISGENET plus information on diseases associated with human genes are available to UniProt/SwissProt human protein entries.
https://t.co/5069prCDF3
https://t.co/8jiepUYkoC

[Innovative Health Initiative @IHIEurope]

IMI project result: our @etransafe project developed an 'app' to make it easier for researchers to analyse which #biomarkers are being used in which #clinical studies.
Find out more: https://t.co/aBAQ9PGwvK

[MedBioInformatics Solutions @MedBioSolutions]

@GenPenAI You can test it by registering for a free trial

[MedBioInformatics Solutions @MedBioSolutions]

🗣️New release of DISGENET plus (v22)
🧬New associations: more than 40K new GDAs and VDAs in the DB
🧪New search functionalities for chemicals in the web and the REST API
⚕️New semantic relations between diseases
👉🏽To learn more about the new features: https://t.co/EWxxUItnIF

[MedBioInformatics Solutions @MedBioSolutions]

🗣️New article from our team! Benchmarking of #network #biology approaches for systems #toxicology This work is part of our efforts to develop #insilico novel approaches for #chemical #riskassessment in the context of @RISKHUNT3R
https://t.co/qpazKz7ocZ

[DisGeNET @DisGeNET]

🗣️Check out our new article! Visualization of automatically combined #diseasemaps and #pathway diagrams for #rarediseases

https://t.co/UiZ8Z7GWts
https://t.co/K0YVPgqX3I

[UPF Medicine and Life Sciences @UPFbiomed]

🔗Curious to learn more? Check out the published results in @NatRevDrugDisc: https://t.co/CA0Di4V8My #ScienceResearch #DrugSafety
@etransafe

[UPF Medicine and Life Sciences @UPFbiomed]

💻 Interesting tools emerged from the project, including ToxHub, a platform with access to over 10,000 drug safety studies. Plus, Flame, an open-source machine learning app for building and sharing models predicting biological properties of new compounds.
#MachineLearning

[UPF Medicine and Life Sciences @UPFbiomed]

🙌🏽 Academically coordinated by the @UPFBarcelona's Prof. Ferran Sanz, coordinator of the Biomedical Informatics Research Unit at GRIB, the project involved researchers from @GRIB_Barcelona and @MedBioSolutions

[UPF Medicine and Life Sciences @UPFbiomed]

📢 Culmination of the eTRANSAFE project to share data on the safety of medicines

📈 The project has integrated, in a single platform, data from more than 10,000 pharmacological studies from 13 leading pharmaceutical companies.
#DrugSafety
👉🏽https://t.co/y9TMyL1Oqh

[MedBioInformatics Solutions @MedBioSolutions]

#medbioinformaticssolutions has achieved the Innovative SME seal, a recognition given to small and medium-sized enterprises with an innovative character. The Spanish Ministry of Science and Innovation grants this distinction to reward those SMEs with great activity in R&D.

[MedBioInformatics Solutions @MedBioSolutions]

We are proud to have been part of @etransafe to empower translational #safetyassessment with #DataScience #textmining #AI #networkscience https://t.co/Sxm8H12Wkb

[eTRANSAFE Project @etransafe]

Fresh from the oven - check out the latest publication from eTRANSAFE! https://t.co/ec9HaRufSs

@IHIEurope
#H2020 #toxicology #drugsafety #insilico

[MedBioInformatics Solutions @MedBioSolutions]

While only a dozen #biomarkers are approved by the FDA, many are evaluated in the context of #clinicaltrials. We uncover data on #biomarkers and their use from #freetext using #NLP and make it available through our DISGENET plus platform
To learn more 👇🏽
https://t.co/BkFWLByXuN

[MedBioInformatics Solutions @MedBioSolutions]

Our new approach to extract information from #biomarkers from #clinicaltrials using #textmining to identify and classify biomarkers.
Learn more on patterns of use of biomarkers across therapeutic areas over time
👉🏽https://t.co/iYdUilgAag
👉🏽https://t.co/dB4opTiUPM

[MedBioInformatics Solutions @MedBioSolutions]

New features for 2023!
-New functionality to search for drugs 💊
-New information on biological pathways 🧫
-GoF and LoF mutations associated with disease 🧬

👉🏽To learn more about the new features, visit us https://t.co/BkFWLBzvkl

[MedBioInformatics Solutions @MedBioSolutions]

Congrats to Jordi Valls-Margarit for best poster award with his work on #insilico tools for #chemical #riskassessment 🧪🧬💊@RISKHUNT3R

[RISK-HUNT3R @RISKHUNT3R]

#ASPIScluster #OpenSymposium just started at #ESTIV2022, with focus on the joint (@ONTOX_EUproject, @RISKHUNT3R, @PrecisionTox) framework developed to implement #nonanimal based technologies in #riskassessment.
https://t.co/Iz3z1W1XLd.
#JRC #H2020 @EU_HaDEA
#NAMs #AOPs #3Rs

[MedBioInformatics Solutions @MedBioSolutions]

👉🏽 Check our new post on genetic support for FDA drug approvals in 2021
🧬DISGENET plus has genetic support for 90% of FDA drug approvals in 2021
📚This surpasses publicly available resources, which support 66% of drug approvals
#drugefficacy #Genetics
https://t.co/BvnJJsqRYn

[ELIXIR Europe @ELIXIREurope]

Finally, the flash talks ⚡ session moderated by @montsedabanm from @biocat_en.
💬 We have different organisations sharing their works and experiences!

@genomcore @madeofgenes @permedcoe @BSC_CNS @butlersci @IMOMA_Asturias @MedBioSolutions